Stopping Cancer in its Tracks – Telomerase Receptor Inhibition

Last month, CU Nobel Prize Winner Tom Cech (Check) and colleagues announced a breakthrough in their quest to stop cancer.  It involves an enzyme known as telomerase (tell-AH-mer-aze), which helps cells divide almost endlessly – helpful when a child is growing.  In adults, most cells stop responding to telomerase.  Instead they save up a limited number of cell divisions timed to last through old age.  Cancer cells are different.  They are great gobblers of telomerase.  That’s where CU discovery comes in.  It’s a way to possibly prevent cancer cells from tanking up on telomerase.  Cech says that while human trials are years off, the discovery looks promising.  For more, here’s How on Earth’s Shelley Schlender, talking with CU Nobel Prize winner, Tom Cech, in an extended version of this interview on cancer:

Play

4 thoughts on “Stopping Cancer in its Tracks – Telomerase Receptor Inhibition”

Leave a Reply to Media Mining Digest 53 – Nov 16, 2012: Entrepreneur CEO Engineer, Telomerase Use, Implant Reuse, Blood Type Impact, Web Site Design, Legends of Mushuau Innu, Jewish Fundamentalism, Hospital Stories, Fish Oil and Tamiful Issues, Podcast Help, Pensions, S Cancel reply

Your email address will not be published. Required fields are marked *